SVOD participants will have a chance to attend seminars taught by the Stanford Graduate School of Business professors, Silicon Valleyventure capitalists, and high level business professionals. Participants will be offered an opportunity to develop their own schedule of seminars based on their personal interests and educational needs. Seminars are open only to the registered participants.

Several seminars will be offered at certain time slots. To facilitate the choice of seminars by participants, each seminar is assigned a track according to the audience to which it is recommended:

ENT - general entrepreneurship
VC - venture capital
ACAD - commercialization of academic science
BIO - life sciences
BD - business development

Seminars are only offered on November 14.
Seminars are subject to change at any time without notice.

		Track
9:00 AM-10:30 AM Main Hall	ENTREPRENEURSHIP: FOUNDING AND FUNDING A NEW VENTURE Charles A. Holloway Kleiner Perkins Caufield and Byers Professor of Management, Graduate School of Business, Stanford University Max Levchin Founder and CEO, Slide; co-founder and former CTO, PayPal John Malloy Managing General Partner, BlueRun Ventures Venture funding is one of many ways available to an entrepreneur to finance a growing company. Would your company benefit from venture financing? The session will cover the following topics: • Start-up: financing strategies • Pros and cons of getting funded by a venture capital firm • What venture capitalists are bringing to the table • When and how to approach venture capitalists	ENT
10:30 AM-11:30 AM Main Hall	VALUATION AND FINANCING FOR ENTREPRENEURS: A ONE-HOUR CRASH COURSE Ilya A. Strebulaev Assistant Professor of Finance, Graduate School of Business , Stanford University • How to come up with an estimation of the value of your project/firm? • How to finance your idea to make it into a successful project into a successful company? • How to write financial contracts with your money providers? • How to optimize your exit strategy?	ENT
Room Q2	VENTURE CAPITAL BUSINESS MODEL; STRUCTURE OF A VENTURE FUND Alexei Andreev Managing Director and Executive Vice President, Harris & Harris Group How do venture capitalists make money? What creates an incentive for them to build successful businesses? This session will cover the basis of venture capital business models in the United States : • Legal and financial structure of a venture capital fund: Limited and General Partners • Financial mechanisms of venture capital: capital commitment, capital call, carried interest	VC
Room Q1	PATH TO MONEY AND MARKETSHARE: AN INTRODUCTION TO TECHNOLOGY LICENSING AND OPEN SOURCE LICENSING Chris Nadan Associate General Counsel and Director for Sun Microsystems, Inc. Most of the product development and marketing in technology business are capital intensive programs. In many cases the company doesn't have sufficient resources to develop or market its product in house. Is out-licensing the intellectual property to big players in the field the best solution in this case? The seminar will discuss: • Types and terms of licensing agreements • Strategic decisions and negotiating a licensing deal	BD
11:30 AM-12:30 PM Main Hall	VENTURE CAPITAL VALUE ADDED: WHAT VENTURE CAPITALIST BRINGS TO THE TABLE Franklin "Pitch" Johnson Founding Partner, Asset Management Company Venture capitalists invest much more than just cash in their portfolio companies: they invest their time, experience, and network to help entrepreneurs build their ventures. This session will discuss: • Finding the right venture investor • Venture capital value added: what to expect from a venture capitalist • Venture capitalist as your Board member	ENT
Room Q1	VENTURE INVESTING IN LIFE SCIENCES Dr. Albert Cha Managing Partner, Vivo Ventures Funding a biomedical startup is quite different from funding a technology company. There is a set of milestones determined primarily by the regulatory process of a medical product approval in the United States . These milestones drive all aspects of venture funding and the valuation of the company. The seminar will discuss: • Finding the right venture capitalist for your life sciences company • Venture capital process in Life Sciences • Fundable milestones and valuation • Product development and exit strategies	BIO
1:00 PM-2:00 PM Main Hall	STRUCTURING A VENTURE CAPITAL DEAL Kirk Dunn CEO, PowerFile Once you know that your company will benefit from venture money, you have made your pitch and got the interest – what is the next step? How to lay a ground for the long-term successful relationship? The session will focus on the following topics: • Specific due diligence terms you need to be aware of • Essentials of the legal terms of financing • Valuation and fundable milestones • How to create a win-win term sheet? • Exit Strategies: three practical ways	ENT
Room Q1	DEVELOPING SUCCESSFUL BIOMEDICAL PRODUCT Barry M. Sherman Executive Vice President, Development, BiPar Sciences, Inc. The session will focus on the product development process of drugs and medical devices in the United States . Discussion topics include: • Fundamentals of biotech product positioning • FDA process and product development • Marketing and sales of a new product line in the United States • Building successful corporate relationships	BIO
Room Q2	IP STRATEGIES FOR START-UPS Daniel L. Appleman Partner, Heller, Ehrman, White, & McAuliffe The session will cover the essentials of startup intellectual property issues: • How to leverage intellectual property as a strategic asset to build a successful company • Intellectual property protection • Technology transfer	ENT
2:00 PM-3:00 PM Main Hall	GETTING READY FOR A PRODUCT LAUNCH Dave Girouard General Manager, Google Enterprise The session will focus on the issues related to successful launch of the high technology product in the US market. Discussion topics: • How to position yourself for success: market assessment and competitive analysis to define value proposition • How to plan the launch: coordinating R&D, product management and marketing efforts. • Creating the buzz: communicating your value proposition to the customers, partners and press.	ENT
Room Q1	ESTABLISHING CORPORATE PRESENCE IN US Leo Ryzhenko President, US Business Services This session will cover essentials of startup organization and building a growing enterprise: specifics of US legal, accounting and taxation issues, as well as marketing and professional services entrepreneurs need to be aware of. The seminar will cover such practical issues as: • Setting up an office in the United States • Legal aspects of starting business in US • Finding and using vendors and professional services • What not to do	ENT
3:00 PM-4:00 PM Room Q1	BUILDING A BUSINESS TEAM Alec Miloslavsky Head of Product Development and Strategy & Co-Founder, Exigen Group, Inc. Finding managerial and business talent in the United States is the largest challenge that an entrepreneur from another country may face. Where to find the best CEO? Why are those sales people so expensive? The seminar will cover the following topics: • US management team: the key success factor • Building your first Board of Directors and Scientific Advisory Board • Leveraging your relationships with venture capitalists • Headhunters: pros and cons	ENT
Main Hall	START-UP EXIT STRATEGIES Gary Benton Partner, Pillsbury Winthrop Shaw Pittman LLP Byron Deeter Venture Partner, Bessemer Venture Partners The venture capitalist starts thinking about exiting the deal when he makes the investment. The seminar will discuss which exit strategies are available for the venture capitalist and their advantages: • IPO: windows of opportunity • Mergers and Acquisitions • The role of financial intermediaries • Exit valuations	VC
Room Q2	LICENSING A BIOMEDICAL PRODUCT AND DEVELOPING SUCCESFUL CORPORATE RELATIONSHIPS Brad W. Crawford Director Licensing, Amgen, Inc. Licensing is a viable option for many biotech companies that don't have substantial resources for product development • How to approach licensing partners in the US • Licensing terms and conditions • Win-win licensing deals	BIO
4:00 PM-5:00 PM Room Q1	VENTURE CAPITAL PROCESS: WHAT INVESTORS LOOK FOR Peter Loukianoff Partner, Alloy Ventures Raising money is not an easy process. How do you package your company to be an attractive venture investment target? The seminar will discuss the following topics: • Key success factors in fundraising • Executive summary and its role in the process • What is a successful pitch? • Writing a business plan: some of the best recipes	ENT
Main Hall	BUILDING A SUCCESSFUL VENTURE PORTFOLIO Steve Jurvetson Managing Director, Draper Fisher Jurvetson What makes a successful venture capital firm? This seminar will cover the aspects of venture capital process from an investor’s perspective and strategies of building and managing a successful venture portfolio: • Due diligence process • Leading vs. following • Building syndicates • Helping the companies to grow and exit • Managing a portfolio of private companies	VC

There will be Special Programs for US Venture Capital Investors (marked USVC) and representatives of the Russian academic science and technology parks (marked ACAD) on November 15: